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MicroRNA cluster miR199a/214 are 
differentially expressed in female 
and male rats following nicotine 
self-administration
Steven T. Pittenger1,4, Victoria L. Schaal3, Dalia Moore2, Rahul S. Guda3, Sneh Koul3, 
Sowmya V. Yelamanchili2, Rick A. Bevins1 & Gurudutt Pendyala3
Previous research has established sex differences associated with nicotine intake, however a significant 
gap in knowledge remains regarding the molecular mechanisms that govern these differences at the 
transcriptional level. One critical regulator of transcription are microRNAs (miRNAs). miRNAs are a 
family of non-coding RNAs that regulate an array of important biological functions altered in several 
disease states, including neuroadaptive changes within the brain associated with drug dependence. 
We examined the prefrontal cortex (PFC) from male and female Sprague-Dawley rats following self-
administration (22 days) of nicotine or yoked saline controls using next generation RNA-Sequencing 
(RNA-Seq) technology and found an array of miRNAs to be significantly and differentially regulated 
by nicotine self-administration. Of these, we found the expression of miR-199a and 214, which are 
expressed on the same cluster of chromosome 1, to be upregulated in the female rats exposed to 
nicotine; upregulation in this group was further validated by real time polymerase chain reaction (RT-
PCR). Bioinformatics analysis to assess common targets of miR-199/214 identified Sirtuin 1 (SIRT1), 
a nicotinamide adenine dinucleotide (NAD)- dependent deacetylase that plays a role in apoptosis, 
neuron survival, and stress resistance. Using western-blot, we confirmed downregulation of SIRT1 and 
increased cleaved caspase 3 expression in the brains of nicotine-exposed female rats and no change 
in expression levels in the other groups. Collectively, our findings highlight a miR-199/214 regulatory 
network that, through SIRT1, may be associated with nicotine seeking in females which may serve as a 
potential therapeutic target for sex-specific treatment approaches.
Smoking remains a significant health and economic burden in the United States, resulting in 480,000 deaths and 
costing more than $300 billion annually1. While many smokers report a desire to quit, most are unsuccessful in 
quit attempts2. The tenacity of this addiction can be, in part, attributed to nicotine, the primary addictive constit-
uent in cigarettes3. Notable sex differences related to smoking and quitting have been identified [for a review see4]. 
While men are more likely to be smokers and smoke more cigarettes per day, women develop dependence to nic-
otine more rapidly. Women also have higher relapse rates than men and nicotine replacement therapy may be less 
effective4–6. These differences may reflect women’s greater sensitivity to non-pharmacokinetic effects of nicotine4,7.
While environmental and social factors likely play a role in some of these nicotine sex differences, biological 
factors including the effect of gonadal hormones on nervous system development, changes in circulating gonadal 
hormones across the lifespan, and differential expression of X and Y genes have also been implicated8–12. These 
factors produce well-described sex differences in the bio-behavioral processes that contribute to drug addiction–
learning and memory, drug efficacy and toxicity, neuroinflammation, etc.13–16. Concomitantly, sex differences in 
pre-clinical animal models have also been demonstrated. Females rats show greater nicotine-induced locomo-
tor sensitization, more pronouced withdrawal following nicotine cessation, enhanced conditoned reinforcement 
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to nicotine-associated cues, and higher break points on a progressive ratio nicotine self-administratin sched-
ule4,17–19. Previous studies have also demonstrated that endogenous neuropeptide experession is sex-dependently 
altered following nicotine self-administration20. Tissue levels of neurotensin in the PFC were increased in the 
male, but not female, rats following nicotine self-administration compared to saline controls, implicating the PFC 
as an area of interest when exploring sex differences related to nicotine intake20.
While nicotine sex differences have been established, a significant gap in knowledge remains regarding the 
molecular mechanisms that govern these differences at the transcriptional level. One critical regulator of tran-
scription are microRNAs (miRNAs), which are a family of non-coding RNAs. At the molecular level miRNAs 
are about 21–23 nucleotides long and regulate gene expression through direct binding to the 3′ untranslated 
region (UTR) of gene targets, thereby inhibiting their translation into protein21. From a pathological perspective, 
miRNAs have been shown to regulate an array of important biological functions in several diseases including 
neuroadaptive changes within the brain caused by drugs of abuse22–24.
Given the effects of nicotine on brain areas involved in emotional and cognitive processing, we per-
formed RNA-Seq on the prefrontal cortex (PFC) from female and male rats following long-term nicotine 
self-administration. The PFC was selected as it is critically involved in higher-order executive function, as well as 
regulation of behaviors associated with drug abuse and withdrawal in humans25–27 and non-human animals28–30. 
PFC involvement in the modulation of maladaptive behaviors associated with stimulant dependence is well sup-
ported, however little is known regarding differential PFC miRNAs expression between sexes in a preclinical 
animal model of nicotine taking (i.e., self-administration). Using RNA-Seq technology, which enables rapid 
and quantitative profiling of the transcriptome, we profiled the PFC of male and female Sprague Dawley rats 
that self-administered nicotine (0.0073 mg/infusion) or received yoked saline infusions for 22 days on a vari-
able ratio 3 (VR3) paradigm to identify differentially expressed miRNAs. Nicotine self-administration in the 
females had a more notable effect compared to the males. Among the differentially expressed miRNAs, miR-
199a and 214, which are both expressed on the same cluster of chromosome 1, were upregulated in the female 
rats self-administering nicotine compared to males. This was validated by real time polymerase chain reaction 
(RT-PCR). Further, bioinformatics analysis to assess common targets of miR-199/214 identified Sirtuin 1 (SIRT1), 
a nicotinamide adenine dinucleotide (NAD)- dependent deacetylase that plays a role in apoptosis, neuron sur-
vival, stress resistance, and regulation of drug dependence31–34. Using western-blot, we confirmed expression of 
SIRT1 was only downregulated in the brains of nicotine exposed female rats, with no expression change in the 
males. To our knowledge, this is the first study to employ nicotine self-administration paradigm coupled with 
next generation sequencing technology to identify sex-specific miRNA signatures associated with long term nic-
otine self-administration. Collectively, our findings highlight a miR-199/214 regulatory network via downregula-
tion of SIRT1 to be associated with nicotine self-administration in females but not males.
Results
Nicotine maintained robust self-administration. Both male and female rats maintained robust 
self-administration of nicotine on a VR3 schedule over the 22 sessions, while yoked-saline maintained very lit-
tle responding (Fig. 1A). For active lever presses, there was a main effect of Group [F(1,21) = 410.25, p < 0.01] 
and Session [F(21,441) = 8.97, p < 0.01] but no effect of Sex (F < 1, p = 0.66). The 3-way Sex x Group x Session 
interaction [F(21, 441) = 1.03, p = 0.42] and the 2-way Sex x Group interaction [F(1,21) = 2.28, p = 0.14] were 
not significant. The Group x Session interaction was significant [F(21, 441) = 15.00, p < 0.01]. Saline-yoked rats 
responded more on session 1, but the nicotine rats responded more on sessions 2 to 22. The Sex x Session interac-
tion was also significant [F(21,441) = 2.30 p < 0.01]; the female rats responded more than males on sessions 1 and 
3 with equivalent responding on all other sessions. Responding on the inactive lever quickly decreased (Fig. 1B), 
demonstrating a clear discrimination between the active and inactive lever in male and female nicotine rats. For 
inactive lever presses, there was a main effect of Session [F(21,441) = 39.01, p < 0.01], but no main effect of Sex 
[F(1,21) = 1.79, p = 0.19] or Group [F(1,21) = 1.89, p = 0.18]. The 3-way interaction of Sex x Group x Session 
[F(21,441) = 1.49, p = 0.07], the 2-way interaction of Sex x Session [F(21,441) = 1.04, p = 0.40] and the 2-way 
interaction of Sex x Group (F < 1, p = 0.43) were not significant. There was a significant interaction of Group x 
Session [F(21,441) = 1.66, p < 0.05], with saline-yoked rats responding more on the inactive lever on session 1 
and the nicotine rats responding more on the inactive lever on sessions 2, 5, and 11.
Interestingly, when differences in body weight were accounted for, males and females did differ in total nico-
tine intake [Fig. 2; t(11) = 4.886 p < 0.001]. Females (10.83 ± 0.35 mg/kg) had greater total nicotine intake than 
the males (8.01 ± 0.44 mg/kg) (Fig. 2A) when intake over all 22 days are summed. Male and female nicotine rats 
displayed an increase in general locomotor activity (Fig. 2B). There were main effects of Group [F(1,21) = 7.12, 
p < 0.05] and Session [F(21,441) = 6.21, p < 0.01] but no main effect of Sex (F < 1, p = 0.60). The 3-way Sex x 
Group x Session [F(21,441) = 1.07, p < 0.37], the 2-way Sex x Group (F < 1, p = 0.81), and the 2-way Sex x Session 
(F < 1, p = 0.68) interactions were not significant. There was a Group x Session interaction [F(21,441) = 3.26, 
p < 0.01]; the nicotine rats showed more general locomotor activity than the saline-yoked rats on sessions 2 to 22.
Differential expression of miRNAs post nicotine exposure. Following completion of the 22 
self-administration sessions, total PFC RNA isolated from individual animals was subjected to miRNA sequenc-
ing using an RNA-Seq approach to identify differential miRNAs as sex-specific signatures associated with chronic 
nicotine exposure. We obtained between 5 and 34 million raw reads per sample per condition and observed an 
overall greater than 83% of mapped reads between the sexes (Supplemental Table 1). Among the 688 miRNAs 
profiled (Supplemental Table 2), we identified 45 miRNAs, 23 in females and 22 in males, to be differentially 
expressed after nicotine self-administration (Fig. 3A). Amongst the 23 miRNAs in females, 10 were up regulated 
and 13 down regulated while in the males, 9 were up regulated and 13 down regulated (Table 1). Interestingly, the 
overall levels of expression of the differentially expressed miRNAs were more subtle in the males post nicotine 
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intake. Females, on the contrary, showed enhanced and robust expression of some miRNAs. Further applying a 
cutoff of ±1.5 fold change and p < 0.05 as our criteria, we found four miRNAs to be up regulated in the females 
post nicotine intake: miR-214-3p (+7.94 fold), miR-350-5p (+4.44), miR-19a-3p (+2.14), and miR-199a-5p 
(+1.77). For the males, only miR-451-5p (+1.69) was up regulated. None of the down regulated miRNAs met cri-
teria in the females. However, miR-760-5p (−1.58 fold) was down regulated in the males after nicotine exposure.
Notably, miRs-199 and 214, which are co-expressed on the same cluster of chromosome 1, was significantly 
up regulated in female rats exposed to nicotine compared to males that received nicotine. The up regulation 
of these miRNAs solely in females self-administering nicotine and not in the males was further validated by 
RT-PCR (Fig. 3B). For miR-199a, the 3-way interaction of Sex x Group x Session [F(1,20) = 4.437, p = 0.048], 
the 2-way interaction of Sex x Session [F(1,20) = 4.481, p = 0.047] and the 2-way interaction of Sex x Group 
[F(1,20) = 5.146 p = 0.035] were significant. Similarly, for miR-214 the the 3-way interaction of Sex x Group x 
Session [F(1,16) = 10.14, p = 0.058], the 2-way interaction of Sex x Session [F(1,16) = 10.16, p = 0.006] and the 
2-way interaction of Sex x Group (F(1,16) = 5.686, p = 0.030) was significant.
SIRT1 is a target of miR-199 and 214. As miRNAs can regulate the expression of several gene targets, 
we performed bioinformatics analysis to assess the common targets of miR-199 and 214 (Supplemental Table 3). 
One prominent target we identified was SIRT1 which plays a significant role in cellular processes33. Western blot 
analysis on the brain lysates showed a significant decrease in SIRT1 expression in the nicotine exposed female 
rats (3-way interaction of Sex x Group x Sesssion F(1,24) = 7.231, p = 0.013) but not in the males (Fig. 4A,B). The 
decrease in SIRT1 levels in nicotine self-administering females correlated with increased expression of cleaved 
caspase 3, a pro-apoptotic protein (3-way interaction of Sex x Group x Sesssion F(1,24) = 17.81, p < 0.001). 
Cleaved caspase did not differ between the male nicotine self-administration and yoked saline controls. To fur-
ther elucidate if other brain regions unrelated to drug abuse also show sex-specific difference with SIRT1 expres-
sion, we examined the cerebellum and hippocampus. We observed no significant change in SIRT1 expression in 
both the brain regions with nicotine intake between the two sexes (Supplementary Figs 1 and 2). These data col-
lectively show that down regulation of SIRT1 by nicotine is specific to regions involved in drug seeking and more 
Figure 1. Nicotine maintained robust self-administration. (A) Active lever presses for females (left panel) and 
males (right panel) receiving nicotine infusions on a VR3 schedule of reinforcement (circles) or yoked-saline 
infusions (squares). Yoked-saline infusions were administered contingent on responding from a nicotine 
partner. That is, yoked rats did not control the saline infusions. (B) Inactive lever presses for females (left panel) 
and males (right panel) receiving nicotine infusions on a VR3 schedule of reinforcement (circles) or yoked-
saline infusions (squares).
www.nature.com/scientificreports/
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specifically in female rats. In summary, our current findings demonstrate the co-expressed miRNAs 199 and 214, 
and their common gene target SIRT1 to be associated with chronic nicotine taking in female, but not male rats.
Discussion
Studies investigating potential sex differences in nicotine dependence have now begun to document evidence 
that women, despite being less prone to smoking, often show more pronounced measures of withdrawal and are 
more likely to relapse6,35–38. Using the rodent IV drug self-administration model that mimics human drug-taking 
behavior, we allowed male and female rats to self-administer IV nicotine for 22 days. Consistent with our recently 
published study20, we found that both male and female rats readily self-administered nicotine. In that study, we 
found that female rats had higher total nicotine intake than males (+1.26 fold), although in that study it did not 
meet the threshold for statistical significance. In the current report, we observed the same pattern with total 
intake in the females significantly higher than the males (+1.35 fold). Higher nicotine intake in females is in line 
with previously published works5,17,39–42. One possible reason for the higher intake in females could be the stage 
of estrous, which has been associated with the observed sex differences with drugs of abuse43,44. Previous studies 
have reported that intact female rats show greater behavioral response to psychostimulants such as cocaine in 
estrus compared to other stages of the estrous cycle45 or to males46. This observation further draws support from 
another study which showed females reaching higher breaking points during estrus than during other stages of 
the estrous cycle on a progressive ratio of cocaine self-administration47.
While there have been reports of some behavioral sex differences associated with chronic nicotine intake, the 
molecular mechanisms contributing to these observed sex differences remain poorly explained. The goal of the 
current study was to identify sex-specific miRNA signatures associated with chronic nicotine intake. miRNAs 
represent a class of noncoding RNAs that critically regulate gene expression by binding to the 3′ UTR of target 
Figure 2. Nicotine intake and locomotor activity. (A) Total nicotine intake throughout self-administration is 
displayed for female (closed circle) and male (open circle) rats. (B) Locomotor activity for females (left panel) 
and males (right panel) receiving nicotine infusions on a VR3 schedule of reinforcement (circles) or yoked-
saline infusions (squares).
Figure 3. Differentially expressed miRNAs and post validation. (A) Venn diagram showing differentially 
expressed miRNA between males and females post nicotine self-administration. The color code represents the 
expression levels (Red- up and Green – down). (B) Validation of the increase in expression of miR-199a and 
miR-214 in female rats that self-administered nicotine compared to saline controls. Overall 2-Way ANOVA 
(hatched line) with Sidak’s multiple comparison test (*p < 0.05 and **p < 0.01) was used to determine 
significance. ns- not significant.
www.nature.com/scientificreports/
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transcripts, thus blocking their translation. Several studies have documented the role of these miRNAs in a pleth-
ora of diseases including maladaptive behavior associated with addiction to drugs of abuse22–24. Our current study 
did identify differentially expressed miRNAs between male and female rats post nicotine self-administration. 
While the relative expression levels of the significantly regulated miRNAs in males were subtle, females showed 
more robust changes in expression. The increase in miRNA expression may be a result of the elevated nicotine 
intake in the females, including the role of estrous as noted above, compared to the males.
Among the differentially regulated miRNAs in nicotine-taking females, we found miR-199 and 214, which 
are co-expressed on chromosome 1, to be up regulated. Co-expression studies showing the implications of miR-
199a and 214 dysregulation have been very limited. Studies have implicated these miRNAs in several types of 
cancers48–50, and their roles have been documented in neural development51,52. Using a self-administration model 
Females Males
miRNA
Fold 
Change p-value miRNA
Fold 
Change p-value
rno-miR-214-3p 7.94 4.28E-02 rno-miR-451-5p 1.69 2.41E-02
rno-miR-350-5p 4.44 4.07E-02 rno-miR-19b-3p 1.35 1.85E-02
rno-miR-19a-3p 2.14 2.07E-02 rno-miR-127-5p 1.3 4.47E-02
rno-miR-199a-5p 1.77 2.62E-02 rno-miR-501-3p 1.28 3.63E-02
rno-miR-378a-5p 1.38 2.74E-02 rno-miR-125a-3p 1.25 3.81E-02
rno-miR-142-3p 1.29 3.08E-02 rno-miR-7a-1-3p 1.22 1.38E-02
rno-miR-344b-5p 1.26 3.98E-02 rno-let-7a-1-3p 1.21 2.17E-02
rno-miR-129-5p 1.2 1.10E-02 rno-miR-20a-5p 1.21 3.55E-02
rno-miR-30d-3p 1.17 1.85E-02 rno-miR-505-3p 1.21 3.82E-02
rno-miR-30c-5p 1.15 4.03E-02 rno-miR-664-3p 1.19 2.86E-02
rno-miR-376c-3p −1.36 1.37E-02 rno-let-7d-3p 1.17 4.60E-02
rno-miR-151-5p −1.33 1.55E-02 rno-miR-140-5p 1.16 1.61E-02
rno-miR-376a-3p −1.33 2.77E-02 rno-miR-369-3p 1.16 3.93E-02
rno-miR-218a-5p −1.3 2.32E-02 rno-mir-760-5p −1.58 3.33E-02
rno-miR-376b-3p −1.26 2.05E-02 rno-miR-374-3p −1.39 3.74E-02
rno-miR-376b-5p −1.25 1.21E-02 rno-miR-499-5p −1.29 9.67E-03
rno-miR-382-3p −1.23 1.47E-02 rno-miR-24-2-5p −1.29 1.64E-02
rno-miR-126a-5p −1.21 1.95E-02 rno-miR-666-5p −1.23 4.32E-02
rno-miR-31a-5p −1.21 4.09E-02 rno-miR-488-3p −1.22 1.07E-02
rno-miR-411-5p −1.19 6.27E-03 rno-miR-376a-5p −1.19 3.52E-02
rno-miR-212-3p −1.15 3.49E-02 rno-miR-873-5p −1.18 3.73E-02
rno-miR-24-3p −1.13 3.91E-02 rno-miR-153-3p −1.13 2.06E-02
rno-miR-136-5p −1.12 2.82E-02
Table 1. Differential miRNAs expression analysis post nicotine self-administration between males and females 
(− sign before the number indicates down regulation).
Figure 4. Validation of SIRT1 downregulation in female rats that self administered nicotine. (A) Representative 
western blot showing a decrease in SIRT1 expression in the brain lysates of female rats that self-administered 
nicotine compared to saline controls. This increase in SIRT1 expression correlated with an increase in cleaved 
caspase 3 expression in the brain lysates of female rats that self-administered nicotine compared to saline 
controls. Male rats that self-administered nicotine did not differ in SIRT1 and cleaved caspase 3 expression 
compared to the saline controls. (B) Quantification of the blots from all the animals used in the study is 
represented as a histogram below. Overall 2-Way ANOVA (hatched line) with Sidak’s multiple comparison test 
(*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001) was used to determine significance. ns- not significant.
www.nature.com/scientificreports/
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of drug-intake, this study revealed that miR-199a and 214 may serve as novel markers associated with sex differ-
ences in nicotine intake. Post-nicotine exposure, females showed a significant increase in both miR-199a and 214 
expression compared to the yoked saline controls. In the males, miR-199a was slightly increased in the nicotine 
group while miR-214 was decreased, albeit both of these miRNAs did not differ significantly compared to the 
saline controls. These findings were validated by RT-PCR.
miRNAs play a critical role in regulating gene expression and can target several gene targets. We performed 
a bioinformatics search that identified SIRT1 as one of the common targets for both miR-199a and 214. Western 
blot confirmed a significant reduction in SIRT1 in female rats that self-administered nicotine vs females that 
were in the saline group, an effect that was not found in the male groups. SIRT1 is a NAD- dependent deacetylase 
belonging to the class III histone/protein deacetylases and a member of the silent information regulator family 
that has been shown to play a significant role in several cellular processes in a number of diseases33. miRNAs have 
been shown to regulate the expression of SIRT1 in different disease models. This includes miR-34a in fatty liver 
disease53, miR-195a in lipotoxic cardiomyopathy and diabetic retinopathy54, and miR-199a in cardiac myocyte 
hypoxia55. Specific to drug dependence, previous work has notably shown that SIRT1 is upregulated in the NAc 
in male mice and rats administered (IP) cocaine, morphine, or heroin34. Although a follow-up study by Ferguson 
and collegues31,32 revealed that although the total number of SIRT1 binding sites is increased following 7 days 
of IP cocaine injections, drug administration results in depletion of SIRT1 from genic regions, specifically gene 
promoters. Divergent results from those studies and the work presented here, are likely a result of the type of drug 
utilized, the region of the brain examined, the sex and type of animal model employed, and the drug administra-
tion paradigm used.
In terms of neurodegenerative disorders, upregulation of miR-142 has been shown to decrease SIRT1 levels 
in a macaque model of neuroAIDS56,57. A recent study demonstrated that upregulation of miR-199a-5p caused 
a significant decrease in SIRT1 levels that subsequently led to neuronal loss and apoptosis in a rat model of epi-
lepsy58. The role of SIRT1 in exerting neuroprotection both in vivo and in vitro has been well documented59. In an 
Alzheimer’s disease model, overexpression of SIRT1 caused reduction in beta amyloid production and toxicity60 
as well as prevented neurotoxic tangles by deacetylating the microtubule binding protein tau61. In Huntington’s 
disease, SIRT1 overexpression ameliorates the neurotoxic effect of the mutant protein HTT while overexpression 
reverses this effect59. In a rodent model of Parkinson’s disease, overexpression of SIRT1 caused a reduction in 
alpha synuclein aggregates and increased longevity while knockout mice displayed opposite effects62.
The current study shows that the upregulation of miR-199 and 214 post-nicotine exposure in female rats 
resulted in a significant decrease in SIRT1 levels, which led to an increase in the expression of the pro-apoptotic 
protein cleaved caspase 3 in the PFC, but not in the cerebellum and hippocampus. Decreased neuroprotection 
specifically in the PFC via SIRT1 in females following long-term nicotine administration may play a role in female 
increased vulnerability to nicotine relapse6,38,63 and heighted sensitiveity to nicotine withdrawal4,17–19. Future work 
including a yoked-nicotine control will allow careful examination of how nicotine reinforcment, compared to 
passive nicotine intake, may alter expression of miRNAs. Additionally, a study holding nicotine intake constant 
across sex will allow determination if miRNA expression differences may be a result of differential exposure to 
nicotine in males and females. Future directions of this work will also include examining the effect of molecular 
manipulation of SIRT1 in the PFC of female and male rats on nicotine self-administration. Further, studies aimed 
at dissecting mechanisms associated with the increase in such apoptosis signaling molecules will lend significant 
insights into understanding the sex-based differences associated with chronic nicotine intake.
Materials and Methods
Animals. Sprague-Dawley rats (14 males; 15 females) were purchased from Harlan Laboratories, Inc. 
(Indianapolis, IN, USA) at approximately 9 weeks of age (males 275–300 g; females 175–200 g). Rats were indi-
vidually housed in clear polycarbonate cages (48.3 × 26.7 × 20.3 cm) lined with TEK-Fresh cellulose bedding. 
Rats were allowed ad libitum access to water in home cages throughout the experiment. Following 3 days of 
acclimation to the colony room, food was restricted to maintain 90% of a rat’s free-feeding weight. The colony 
room was temperature and humidity controlled and maintained on a 12 h:12 h light/dark cycle. All experimental 
procedures were performed during the light cycle. Animal procedures and methods employed were approved by 
both the University of Nebraska-Lincoln and University of Nebraska Medical Center Institutional Animal Care 
and Use Committee in accordance with the relevant guidelines and regulations.
Apparatus. Experimental procedures were conducted in 10 conditioning chambers (ENV-008CT; Med 
Associates, Georgia, VT), measuring 30.5 × 24.1 × 21.0 cm, enclosed in sound-attenuating cubicles. Each cham-
ber had a variable-speed syringe pump (PMH-100VS; Med-Associates) located outside the cubicle. Tygon® tub-
ing was threaded from the pump syringe through a leash into the chamber to be attached to the catheter port. 
A recessed receptacle (5.2 × 5.2 × 3.8 cm) was centered on one sidewall of each chamber. A dipper arm could be 
raised to provide access to 0.1 ml of 26% (w/v) sucrose in this recessed receptacle. Two retractable levers were 
located on each side of the receptacle. A white cue-light (2.54 cm diameter; 28 V, 100-mA) was mounted 7 cm 
above each lever and a house-light (two white 28 V, 100-mA lamps) was located in the cubicle, 10 cm above the 
chamber ceiling. An infrared emitter/detector unit was located 4 cm above the stainless steel rod floor and 14.5 cm 
from the side wall containing the receptacle. The number of times this beam was broken provided a measure of 
chamber activity.
Drugs. (-)-Nicotine hydrogen tartrate, obtained from Sigma-Aldrich (St. Louis, MO, USA), was dissolved in ster-
ile saline and pH adjusted to 7.0 ± 0.2. Nicotine was infused intravenously at 35.74 μl over 1 sec at 0.0073 mg/infu-
sion (i.e., 0.03 mg/kg/infusion given an average weight of 243 g per rat). Nicotine dose is reported as the free base.
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Preliminary Lever Training. Following acclimation and food restriction, rats were trained to lever press in 
our lab’s standard procedure20,64,65. Preliminary lever training sessions were initiated by illumination of the house 
light and insertion of one of the two levers (randomly selected). A lever press or a lapse of 15 sec resulted in 4-sec 
access to sucrose, lever retraction, and a timeout (average duration = 60 sec; range = 30–89 sec). After the timeout, 
one of the two levers was again inserted randomly with the condition that the same lever would not be presented 
more than twice in a row. These procedures were repeated until all rats received 60 sucrose deliveries. Daily ses-
sions ranged from 65 to 80 min depending on individual performance. Rats received daily sessions until a lever 
press was made on at least 80% of the lever insertions; all rats learned within 3–5 sessions.
Indwelling Jugular Catheter Surgery and Recovery. Rats were then implanted with indwelling jugular 
catheters following our lab’s standard procedures20,64,66. Briefly, rats were anesthetized with a 2:1 ketamine HCl 
(100 mg/kg) + xylazine HCl (20 mg/kg) cocktail (IM) and prepped for surgery. Two small incisions were made 
below the scapula and the back mount catheter was fit under the skin with the back plate lying flat and the cannula 
port exiting the more rostral incision. Another small incision was then made above the right jugular vein and the 
catheter tubing pulled subcutaneously from the back, over the shoulder, to the neck. The vein was then isolated 
and the catheter tubing fed into the vein and fastened securely. All incisions were then sutured and the rats admin-
istered buprenorphine (0.1 mg/kg) for pain maintenance (also administered 24 h post-surgery) and atipamezole 
(0.5 mg/kg) to terminate anesthesia. Rats then recovered for 7 days, during which they remained in their home 
cages and their catheters were flushed daily with a cocktail of 0.2 ml cefazolin (50 Units/ml) and heparin (30 
Units/ml). Patency was checked on the last day of recovery by IV infusion of 0.05 ml xylazine (20 Units/ml). 
Rats that displayed ataxia (e.g., impaired locomotor function, sedation) within 20 sec were considered patent. Rats 
that were not patent (1 male; 4 females) were excluded from the study.
Post-Surgery Lever Training. After recovery, rats received training sessions with sucrose available on a 
variable ratio (VR) 3 schedule; on average every third response was reinforced (range 1–5 presses). This training 
consisted of 3 daily sessions; during which 1 of the 2 levers was extended into the chamber and then retracted 
following requisite responding. Requisite responding resulted in 4-sec access to sucrose. After sucrose access, 
the opposite lever was inserted and functioned as the active lever. This process was repeated until the end of the 
1-h session. These procedures produce robust lever responding with each lever having an equivalent learning 
history65.
Self-Administration. Prior to the self-administration phase of the experiment, female and male rats 
were separated into two groups creating a total of 4 groups (sample size from post-patency test): nicotine 
self-administration groups (nic-males, n = 7; nic-females, n = 6) and saline-yoked groups (sal-males, n = 6; 
sal-females, n = 5). During self-administration sessions (1 h) both levers were inserted to begin the session. Rats 
in the nicotine self-administration groups received nicotine infusions following responding on 1 of the 2 levers; 
responding on the other lever was recorded but held no programed consequence (i.e., only pressing on the active 
lever was reinforced). Assignment of active and inactive lever was counterbalanced for all groups. The schedule 
of reinforcement in the self-administration phase was again a VR 3. Following the nicotine infusion, a 20-sec 
timeout was signaled by the house light turning on and extraction of the levers. Levers were again inserted and 
the house light turned off following the timeout. Rats in the saline-yoked groups were presented with two inactive 
levers (i.e., responding was recorded but pressing held no programed consequence). Saline-yoked rats received 
saline infusions and signaled timeouts matched to a nicotine self-administering partner’s response pattern. This 
procedure produced controls that had equated handling, chamber exposure, time-outs, etc. yet they were void 
of nicotine exposure. Self-administration sessions were conducted daily for 22 days. Brains were extracted 24 h 
after the last self-administration session. Individual brain regions were immediately dissected, rapidly frozen, and 
stored at −80 °C until further use.
Dependent Measures. Active lever pressing, inactive lever pressing, and activity were the dependent meas-
ures utilized during the self-administration phase. Nicotine intake controlling for body weight was calculated 
by the equation: nicotine intake = [(group average weight (g) used to calculate dose/rat’s weight (g) on each 
self-administration day) * 0.03 mg * infusions earned]. Using this calculation, we were able to keep the dose of 
nicotine per infusion constant and still properly assess possible differences in total nicotine intake20. Total nico-
tine intake was calculated by summing nicotine intake on all self-administration sessions.
Total RNA extraction, Quality control, library preparation and small RNA-Seq. Total RNA 
from the PFC was isolated from individual rats from both sexes and treatment groups using the Direct-Zol 
RNA kit (Zymo Research, USA) based on the manufacturer’s protocol. Quantitation of extracted total RNA 
used Nanodrop 1000 (Thermo Fisher Scientific Inc., USA) and RNA integrity was determined by Agilent 2100 
Bioanalyzer (Agilent Technology, USA). RNA samples were then sent on dry ice to LC Sciences (Houston, TX, 
USA) for miRNA sequencing. Briefly, total RNAs with a RIN value >7 were selected for library construction. 
A small RNA library was generated from the sample using the Illumina Truseq™ Small RNA Preparation kit 
according to Illumina’s TruSeq™ Small RNA Sample Preparation Guide. The purified cDNA library was used 
for cluster generation on Illumina’s Cluster Station and then sequenced on the Illumina HiSeq platform. Raw 
sequencing reads (50 nt) were obtained using Illumina’s Sequencing Control Studio software version 2.8 (SCS 
v2.8) following real-time sequencing image analysis and base-calling by Illumina’s Real-Time Analysis version 
1.8.70 (RTA v1.8.70).
After trimming the adaptor sequence from the raw reads, mappable reads with the length ranging from 15 
to 32 bases were mapped to miRBase v21 and the rat genome. Reads mapped to rat miRNAs in miRbase were 
annotated and the number of mapped reads counted for each identified rat miRNA. The raw counts of reads were 
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normalized by the library size parameter of the corresponding sample. The library size parameter is a median 
value of the ratio between the counts of a specific sample and a pseudo-reference sample. A count number in the 
pseudo-reference sample is the count geometric mean across all samples and was calculated using the formula
=

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 ∏

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where Sj is the library size parameter; cij is the count number of sequence i of sample j; m is the total number of 
samples involved.
Quantiative Real Time PCR. TaqMan miRNA and Gene Expression Assays (Life Technologies, Carlsbad, 
CA, USA) were used for cDNA synthesis and real time PCR according to manufacturer’s instructions. Small 
nuclear RNA U6 (U6) was used as a control for miRNA studies and glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) was used as a control for mRNA studies. Delta-delta Ct method67 was used to calculate fold change 
(2−((CtmiRNA − CtU6)exp − (CtmiRNA − CtU6)control)) or (2−((CtmRNA − CtGAPDH)exp − (CtmRNA − CtGAPDH)control)). Statistical signifi-
cance was determined using ΔCt values (CtmiRNA − CtU6) or (CtmRNA − CtGAPDH).
Bioinformatics Analysis. The detailed sequence information of miR-199 and miR-214 was extracted from 
miRBase (Release 21)68,69. Targets for miR-199 and miR-214-3p were identified using experimentally validated 
miRNA-target interaction database - miRTarBase (Release 6.0)70,71. TargetScan72,73 was used to predicted addi-
tional targets for miR-199-5p and miR-214-3p.
Western blot. Western blot using SDS-PAGE electrophoresis was performed using NuPAGE gel system 
(Invitrogen) as described in our previous studies74,75. Briefly, 30 µg (SIRT1) and 10 µg (cleaved caspase 3) of 
PFC brain lysates from all the animals were separated on a 4–12% and 10% Bis-Tris gels respectively under 
reducing conditions followed by transfer and immunodetection. Nonspecific antibody binding was blocked 
using Superblock (Thermofisher Scientific, Rockford, IL, USA) for 1 h at room temperature. Immunoblotting 
was carried out with antibodies against SIRT1 (1∶1000, Santa Cruz Biotechnology, Santa Cruz, CA) and cleaved 
caspase-3 (1: 1000, Cell Signaling,Technology, Danvers, MA) followed by secondary antibody (1∶3,000 HRP 
conjugated anti rabbit IgG for SIRT1 and 1∶3000 HRP conjugated anti rabbit for cleaved caspase-3 respectively 
(Thermofisher Scientific, Rockford, IL, USA). Blots were developed with 1∶1 solution of Super Signal West Pico 
Chemiluminescent Substrate and Luminol/Enhancer (Thermo Fisher Scientific, Rockford, IL, USA).
Statistical Analyses. Active lever presses, inactive lever presses, and chamber activity were analyzed by 
separate 3-way mixed measures ANOVAs (Type III Sum of Squares) with Sex (male vs female) and Group (nic-
otine vs saline) as between-subjects factors and Session (22) as a within-subjects factor. An independent sam-
ples t test was used to analyze differences in total nicotine intake between females and males in the nicotine 
self-administration groups. Least Significant Difference (LSD) tests were utilized for post-hoc analysis. Statistical 
significance was declared at p < 0.05. For miRNA analysis, after normalization, a student t-test was done to iden-
tify miRNAs showing significant differences between groups (saline versus nicotine for each of the sex). miRNAs 
were filtered using False Discovery Rates (FDR) ≤ 5% and p < 0.05 were considered significant. For the western 
blots, 2-way ANOVA followed by Sidak’s multiple comparision test with p < 0.05 was considered significant. All 
statistical tests were performed with GraphPad Prism (La Jolla, CA, USA); data represented as Mean ± SEM on 
the graphs.
Data Availability
Most of the data generated or analyzed during this study are included in this published article (and its Supplemen-
tary Information file). All datasets generated during and/or analyzed in the current study are available from the 
corresponding author on reasonable request. All Med-PC programs used to control the behavioral equipment are 
available upon request to RAB at rbevins1@unl.edu.
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